Insider Transactions in Q1 2022 at Clearside Biomedical, Inc. (CLSD)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2022
|
George M Lasezkay CEO |
SELL
Open market or private sale
|
Direct |
10,800
-2.1%
|
$21,600
$2.12 P/Share
|
|
Jan 19
2022
|
Thomas Ciulla Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,050
-2.97%
|
$18,100
$2.13 P/Share
|
|
Jan 19
2022
|
Charles A. Deignan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,833
-2.45%
|
$17,666
$2.09 P/Share
|
|
Jan 18
2022
|
George M Lasezkay CEO |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+15.91%
|
-
|
|
Jan 18
2022
|
Thomas Ciulla Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+12.75%
|
-
|
|
Jan 18
2022
|
Charles A. Deignan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+10.83%
|
-
|
|
Jan 11
2022
|
George M Lasezkay CEO |
SELL
Open market or private sale
|
Direct |
5,100
-1.21%
|
$10,200
$2.46 P/Share
|
|
Jan 10
2022
|
William D. Humphries |
BUY
Exercise of conversion of derivative security
|
Direct |
22,727
+44.53%
|
$0
$0.15 P/Share
|